Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

65429 Press Releases
DateTitleCompany
19 Apr 12 Quintiles’ Digital Media Innovation Receives Further Recognition Quintiles
19 Apr 12 Medivir announces TMC435 in an expanded clinical collaboration Medivir
19 Apr 12 ADDING CHEMO TO RADIOTHERAPY HALVES RISK OF DEADLY BLADDER CANCER RETURNING Cancer Research UK
19 Apr 12 Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson’s Disease Sanofi and Michael J. Fox Foundation
19 Apr 12 Suspicion Index for Niemann-Pick type C disease published in Neurology journal Actelion Pharmaceuticals,
Published by
Packer Forbes
19 Apr 12 Laboratory Corporation of America® Holdings Announces 2012 First Quarter Results Laboratory Corporation of America® Holdings,
Published by
Business Wire
19 Apr 12 Baxter Announces Biologics Capacity Expansion to Support Global Growth in Plasma-Derived Therapies Baxter International Inc.,
Published by
Business Wire
19 Apr 12 Human Genome Sciences Announces Unsolicited Offer from GlaxoSmithKline; HGS Board of Directors Authorizes Exploration of Strategic Alternatives Human Genome Sciences Inc.,
Published by
Business Wire
19 Apr 12 UnitedHealth Group Reports First Quarter Results UnitedHealth Group,
Published by
Business Wire
19 Apr 12 All-Oral Combination of Investigational Hepatitis C (HCV) Compounds Daclatasvir and GS-7977 Achieved Sustained Virologic Response (SVR4) in 100% of Genotype 1 and 91% of Genotype 2 and 3 Treatment-Naïve Patients in Phase II Study Bristol-Myers Squibb Company,
Published by
Business Wire
19 Apr 12 Gilead Announces Sustained Virologic Response Data for 12-Week Regimen of GS-7977 Plus Pegylated Interferon and Ribavirin in Genotype 1 Hepatitis C Patients Gilead Sciences Inc.,
Published by
Business Wire
19 Apr 12 Gilead Announces Early Sustained Virologic Response Rates for GS-7977 Plus Ribavirin in Genotype 1 Treatment-Naïve Hepatitis C Patients Gilead Sciences Inc.,
Published by
Business Wire
19 Apr 12 Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*) Boehringer Ingelheim,
Published by
Business Wire
19 Apr 12 First Ever Data Investigating Interferon-Free Treatment in Hepatitis C Patients Who Have Liver Cirrhosis Shows High Viral Cure Rate Boehringer Ingelheim,
Published by
Business Wire
19 Apr 12 Management of Cold Chains Will be Critical for the Growth of the Healthcare Industry IMARC Group
19 Apr 12 Worldwide Clinical Trials Inc acclaimed by Industry Standard Research as; ‘The CRO to have on your radar’ Worldwide Clinical Trials Inc
19 Apr 12 Could beetroot be the key to a healthy burger? UNIVERSITY OF ABERDEEN
19 Apr 12 Dr. Reddy's to Release Q4 & Full Year FY12 Results on May 11, 2012 Dr. Reddy's Laboratories,
Published by
Business Wire
19 Apr 12 AHF Blasts California for $11M in Research Funding for Gilead’s HIV Prevention Pill AIDS Healthcare Foundation,
Published by
Business Wire
19 Apr 12 Presidio Pharmaceuticals Announces Phase 1a-1b Clinical Results with PPI-668, a Potent Pan-genotypic HCV NS5A Inhibitor Presidio Pharmaceuticals Inc.,
Published by
Business Wire
19 Apr 12 Kal Sundaram Appointed to Taro’s Board of Directors as Chairman Taro Pharmaceutical Industries Ltd.,
Published by
Business Wire
19 Apr 12 ImmunoGen, Inc. Announces Conference Call to Discuss its Third Quarter Fiscal Year 2012 Financial Results ImmunoGen Inc.,
Published by
Business Wire
19 Apr 12 Merck Wins Another FOSAMAX® (alendronate sodium) State Court Trial Merck,
Published by
Business Wire
19 Apr 12 Cubist Pharmaceuticals Reports First Quarter 2012 Financial Results Cubist Pharmaceuticals Inc.,
Published by
Business Wire
19 Apr 12 Vertex Advances INCIVEK™ (telaprevir) and Broad Portfolio of Medicines in Development With Goal of Further Expanding and Improving Treatment for People With Hepatitis C Vertex Pharmaceuticals Incorporated,
Published by
Business Wire
19 Apr 12 Molecular Response Opens Access to Genomic DNA for Research Molecular Response,
Published by
Business Wire
19 Apr 12 Needham & Company, LLC Hires Chad Messer as Senior Research Analyst Covering Biotechnology Companies Needham & Company LLC,
Published by
Business Wire
19 Apr 12 Cannabis Science in Final Negotiations to Purchase 50% of what will be a 10,000 Square Foot Cancer Centre in Arizona With Over 500 Existing Medical Cannabis Patients  Cannabis Science Inc.,
Published by
Business Wire
19 Apr 12 Research and Markets: Myelodysplastic Syndrome - Pipeline Review, H1 2012 Research and Markets,
Published by
Business Wire
19 Apr 12 Scientists Report that Process of Converting Non-Beating Heart Cells into Functional, Beating Heart Cells is Enhanced Using Thymosin Beta 4 in Conjunction with Gene Therapy RegeneRx Biopharmaceuticals Inc.,
Published by
Business Wire
Advertising